These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 11888560

  • 21. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ, Grottick AJ, Menzaghi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al-Shamma H, Smith B, Chalmers D, Behan D.
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
    Kimura Y, Naitou Y, Wanibuchi F, Yamaguchi T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):157-62. PubMed ID: 18582863
    [Abstract] [Full Text] [Related]

  • 24. Central 5-HT2B/2C and 5-HT3 receptor stimulation decreases salt intake in sodium-depleted rats.
    Castro L, Athanazio R, Barbetta M, Ramos AC, Angelo AL, Campos I, Varjão B, Ferreira H, Fregoneze J, de Castro e Silva E.
    Brain Res; 2003 Aug 15; 981(1-2):151-9. PubMed ID: 12885436
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
    Millan MJ, Newman-Tancredi A, Lochon S, Touzard M, Aubry S, Audinot V.
    Pharmacol Biochem Behav; 2002 Apr 15; 71(4):589-98. PubMed ID: 11888550
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H, Saito S, Sakurazawa S, Sasaki M, Usui T, Goto F.
    Pain; 2004 Mar 15; 108(1-2):163-9. PubMed ID: 15109520
    [Abstract] [Full Text] [Related]

  • 30. RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist.
    Harrison AA, Parsons LH, Koob GF, Markou A.
    Psychopharmacology (Berl); 1999 Jan 15; 141(3):242-50. PubMed ID: 10027505
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Peripheral and spinal 5-HT receptors participate in the pronociceptive and antinociceptive effects of fluoxetine in rats.
    Cervantes-Durán C, Rocha-González HI, Granados-Soto V.
    Neuroscience; 2013 Nov 12; 252():396-409. PubMed ID: 23994595
    [Abstract] [Full Text] [Related]

  • 33. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats.
    Kitchener SJ, Dourish CT.
    Psychopharmacology (Berl); 1994 Jan 12; 113(3-4):369-77. PubMed ID: 7862847
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze.
    Lin D, Parsons LH.
    Pharmacol Biochem Behav; 2002 Apr 12; 71(4):581-7. PubMed ID: 11888549
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.